CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 450,000 shares at an average $2.86 ($1,288,597)
- 4 Open-market buy Chief Financial Officer bought 60,000 shares at $5.36 ($321,624)
- 4 Open-market buy President and CEO bought 350,000 shares at an average $4.92 ($1,723,708)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise 10% owner acquired 16,625 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,388 shares at an average $25.04 ($34,760)
- 4 Open-market sale President and CEO sold 8,156 shares at an average $25.05 ($204,335)
- 4 Open-market sale Director sold 1,080 shares at an average $25.05 ($27,056)
- 4 Open-market sale President and CEO sold 5,743 shares at an average $25.05 ($143,872)
- 4 Open-market sale Director sold 1,086 shares at $25.11 ($27,272)
- 4 Open-market sale President and CEO sold 6,181 shares at an average $25.11 ($155,180)
Page 5 of 9 · 166 filings